ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Balance Sheet
NASDAQ:ESLA - Nasdaq - US2975841048 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2024 (2024-6-30) | 2023 (2022-12-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 40.00K | 480.00K | 480.00K | |||
| Cash Equivalents | 1.80M | 4.17M | 2.48M | 4.09M | N/A | |||
| Receivables | N/A | 0.00 | 273.07K | 0.00 | N/A | |||
| Other Current Assets | 437.64K | 288.76K | 10.00K | 140.00K | 140.00K | |||
| Total Current Assets | 2.24M | 4.45M | 50.00K | 620.00K | 620.00K | |||
| Non-Current Assets | ||||||||
| Investments And Advances | N/A | N/A | 9.67M | 45.19M | 45.19M | |||
| Other Non-Current Assets | 1.50M | 0.00 | 276.19K | 0.00 | N/A | |||
| Total Non-Current Assets | 1.50M | 0.00 | 9.67M | 45.18M | 45.18M | |||
| TOTAL ASSETS | 3.74M | 4.45M | 9.72M | 45.80M | 45.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.94M | 135.48K | 140.00K | 70.00K | 70.00K | |||
| Accounts Payable | 5.00K | 0.00 | 330.00K | 0.00 | 0.00 | |||
| Other Current Liabilities | 47.70K | 45.23K | 600.00K | 1.10K | N/A | |||
| Total Current Liabilities | 2.99M | 180.70K | 1.07M | 70.00K | 70.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 30.00K | 30.00K | N/A | |||
| Other Non-Current Liabilities | N/A | 0.00 | 1.55M | 1.55M | 1.55M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 1.58M | 1.55M | 1.55M | |||
| TOTAL LIABILITIES | 2.99M | 180.70K | 2.65M | 1.62M | 1.62M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -22.88M | -19.50M | -2.26M | -1.01M | -1.01M | |||
| Additional Paid In Capital | 24.12M | 24.12M | 445.60K | 34.29K | N/A | |||
| Common Shares | 3.66K | 3.66K | 9.33M | 45.19M | 45.19M | |||
| Treasury Stock | -504.91K | -354.44K | N/A | N/A | N/A | |||
| Shares Outstanding | 36.18M | 36.29M | 2.33M | 5.85M | 5.85M | |||
| Tangible Book Value per Share | 0.02 | 0.12 | 3.03 | 7.55 | 7.55 | |||
| Total Shareholders' Equity | 746.29K | 4.27M | 7.07M | 44.18M | 44.18M | |||
| TOTAL LIABILITIES AND EQUITY | 3.74M | 4.45M | 9.72M | 45.80M | 45.80M | |||
| Statistics | ||||||||
| Current Ratio | 0.75 | 24.65 | 0.05 | 8.86 | 8.86 | |||
| Return On Assets (ROA) | -236.08% | -164.15% | -10.29% | -0.55% | -0.55% | |||
| Return On Equity (ROE) | -1181.57% | -171.09% | -14.14% | -0.57% | -0.57% | |||
All data in USD , ROIC based on taxRate of 0.21